Court Revives Whistleblower Suit Against Novartis Over Gilenya Kickbacks
U.S. appeals court reinstates lawsuit accusing Novartis of illegal kickbacks to boost sales of its MS drug Gilenya. Explore legal, pharmaceutical, and healthcare implications.
A U.S. appeals court revived a whistleblower lawsuit against Novartis for allegedly paying illegal kickbacks to promote its MS drug Gilenya.